MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Qualigen Therapeutics PEG Ratio 2011-2026 | QLGN
Annual PEG Ratio Qualigen Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.000109 | -0.000014 | -0.000144 | -0.000076 | -0.571 | -0.0657 | -0.0184 | -0.0111 | -0.0516 | 0.000535 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.000535 | -0.571 | -0.0718 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M |  USA |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 4.58 | - | $ 11 B |  Australia |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Aptorum Group Limited
APM
|
0.0951 | $ 0.88 | - | $ 6.47 M | China |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 22.67 | - | $ 3.76 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | USA |
 |
Galectin Therapeutics
GALT
|
0.235 | $ 2.32 | - | $ 148 M | USA |
 |
Greenwich LifeSciences
GLSI
|
6.84 | $ 22.8 | - | $ 297 M | USA |
 |
Genmab A/S
GMAB
|
0.277 | $ 26.79 | - | $ 16.8 B |  Danmark |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M |  Israel |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-7.82 | - | 17.91 % | $ 11.1 M | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
-12.8 | $ 102.06 | - | $ 27.2 B | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | USA |
 |
Innoviva
INVA
|
0.012 | $ 23.69 | - | $ 1.6 B | USA |
 |
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.09 | - | $ 437 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 23.29 | - | $ 2.96 B | USA |
 |
Jaguar Health
JAGX
|
-0.000005 | $ 0.24 | - | $ 560 K | USA |
 |
KalVista Pharmaceuticals
KALV
|
0.311 | $ 19.24 | - | $ 1.04 B | Britain |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.48 | - | $ 394 M | Britain |
 |
Kamada Ltd.
KMDA
|
1.39 | $ 8.15 | - | $ 260 M | Israel |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Kazia Therapeutics Limited
KZIA
|
5.03 | $ 11.85 | - | $ 1.57 B | Australia |
 |
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 2.91 | - | $ 4.79 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Evogene Ltd.
EVGN
|
-1.63 | $ 0.79 | -0.65 % | $ 27.9 M | Israel |